Skip to main content
. 2019 Nov 29;19(1):763–770. doi: 10.3892/ol.2019.11165

Figure 2.

Figure 2.

Association of TXNIP expression with patient clinicopathological characteristics. (A) T stage. (B) Lymph-node status. (C) Clinical stage. (D) Grade. (E) Effect of TXNIP expression on the overall survival of patients with CCRCC in The Cancer Genome Atlas datasets. TXNIP, thioredoxin interacting protein; CCRCC, clear cell renal cell carcinoma. *P<0.05 and ***P<0.001.